Ultimately, strategies involving ST3GAL5 and ST8SIA1 overexpression, or inhibition of ST3GAL6, FUT4 and FUT7, could offer new therapeutic avenues for bladder cancer. Here, ST3GAL5 is linked to urinary bladder carcinoma.